Unity Biotechnology (STU:9U90) Current Accrued Expense : €4.77 Mil (As of Mar. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Unity Biotechnology Current Accrued Expense?

Unity Biotechnology's Current Accrued Expense for the quarter that ended in Mar. 2024 was €4.77 Mil.

Unity Biotechnology's quarterly Current Accrued Expense declined from Sep. 2023 (€4.93 Mil) to Dec. 2023 (€1.06 Mil) but then increased from Dec. 2023 (€1.06 Mil) to Mar. 2024 (€4.77 Mil).

Unity Biotechnology's annual Current Accrued Expense increased from Dec. 2021 (€1.75 Mil) to Dec. 2022 (€2.10 Mil) but then declined from Dec. 2022 (€2.10 Mil) to Dec. 2023 (€1.06 Mil).

Unity Biotechnology Current Accrued Expense Historical Data

The historical data trend for Unity Biotechnology's Current Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Unity Biotechnology Current Accrued Expense Chart

Unity Biotechnology Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Current Accrued Expense

Get a 7-Day Free Trial

2.62

1.65

1.75

2.10

1.06

Unity Biotechnology Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Current Accrued Expense	Get a 7-Day Free Trial															4.99	5.00	4.93	1.06	4.77

Unity Biotechnology Current Accrued Expense Calculation

Current Accrued Expense is the expense incurred during the accounting period, but not required to be paid until a later date. It includes compensation, interest, pensions and all other miscellaneous accruals reported by the company.

Unity Biotechnology Current Accrued Expense Related Terms

Thank you for viewing the detailed overview of Unity Biotechnology's Current Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Unity Biotechnology (STU:9U90) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Unity Biotechnology Inc (STU:9U90) » Definitions » Current Accrued Expense

Comparable Companies

Traded in Other Exchanges

UBX:USA 9U90:Germany

Address

285 East Grand Avenue, South San Francisco, CA, USA, 94080

Website

https://www.unitybiotechnology.com

Unity Biotechnology Inc designs therapeutics that prevent, halt, and reverse various diseases of aging. The company focuses on clearing senescent cells, and creating senolytic medicines. Its medicines target vulnerabilities unique to senescent cells to clear those cells from the human body while leaving normal cells unaffected. The firm focuses on age-associated diseases such as osteoarthritis, eye diseases, and pulmonary diseases.

Unity Biotechnology (STU:9U90) Headlines

No Headlines